(Q41456815)

30 September 2017

title

The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line (English)

1 reference

30 September 2017

7

1 reference

30 September 2017

Dodi AI

1

1 reference

30 September 2017

Brett S

2

1 reference

30 September 2017

Nordeng T

3

1 reference

30 September 2017

Sidhu S

4

1 reference

30 September 2017

Batchelor RJ

5

1 reference

30 September 2017

Lombardi G

6

1 reference

30 September 2017

Lechler RI

8

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

European Journal of Immunology

30 September 2017

published in

1 reference

30 September 2017

volume

24

1 reference

30 September 2017

issue

7

1 reference

30 September 2017

page(s)

1632-1639

1 reference

Immunology: The ins and outs of antigen processing and presentations

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

MHC class II-associated invariant chain contains a sorting signal for endosomal compartments

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

MHC class II-restricted presentation of intracellular antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Class II MHC molecules can use the endogenous pathway of antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Biological and biochemical characterization of an SV40-transformed xeroderma pigmentosum cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Generation and characterization of an HLA-DR alpha-specific monoclonal antibody using L-cell transfectants expressing human and mouse class II major histocompatibility dimers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Structure and biosynthesis of the signal-sequence receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240727

7 January 2021

Identifiers

DOI

10.1002/EJI.1830240727

1 reference

30 September 2017

1 reference